Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company's Scientific Advisory Board

DOYLESTOWN, PA / ACCESSWIRE / January 25, 2022 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain management life sciences company, announces today that it has

Related Keywords

Italy ,California ,United States ,Irvine ,Italian ,Kostenloser Wertpapierhandel ,Louise Turner Arnold ,Thoma Kikis ,Daniele Piomelli ,Louie Toma ,Neuropathix Inc ,Pennsylvania Biotechnology Center ,Drug Administration ,Company Twitter ,Company Scientific Advisory Board ,Italian Institute Of Technology ,Cannabinoid Research ,Securities Exchange ,Chemistry At University Of California ,Scientific Advisory ,Nature Medicine ,Nature Neuroscience ,Louise Turner Arnold Chair ,Distinguished Professor ,Pharmaceutical Sciences ,Biological Chemistry ,Italian Institute ,Dean Petkanas ,Bucks County ,Securities Act ,Securities Exchange Act ,Safe Harbor ,United States Controlled Substances ,Neuropathix ,Elcomes ,Daniele ,Iomelli ,Company ,Cientific ,Advisory ,Board ,